Robert Paul Harris, Director at Aralez Pharmaceuticals Inc. (ARLZ), sold 104,778 shares at $4.99 ($523K) on 2016-11-29, disclosed to the SEC on 2016-11-30.
Open-market sale of $523k ARLZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TBUFF | BUY | 2013-03-20 | $558K | — | Filing → |